Royal Bank of Canada Lowers Teladoc Health (NYSE:TDOC) Price Target to $18.00

Teladoc Health (NYSE:TDOC) had its price objective reduced by investment analysts at Royal Bank of Canada from $25.00 to $18.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the health services provider’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 38.36% from the stock’s current price.

A number of other research analysts have also recently weighed in on the stock. Leerink Partnrs restated a “market perform” rating on shares of Teladoc Health in a research note on Monday, February 26th. Evercore ISI lowered their target price on shares of Teladoc Health from $15.00 to $14.00 and set an “in-line” rating on the stock in a research note on Friday. Needham & Company LLC restated a “hold” rating on shares of Teladoc Health in a research note on Friday. DA Davidson lowered their target price on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Finally, Stifel Nicolaus lowered their target price on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday. Eleven research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Teladoc Health currently has a consensus rating of “Hold” and an average price target of $19.67.

Teladoc Health Trading Down 2.4 %

Shares of Teladoc Health stock opened at $13.01 on Friday. The company’s fifty day simple moving average is $14.85 and its 200-day simple moving average is $17.72. The stock has a market capitalization of $2.20 billion, a PE ratio of -9.23 and a beta of 0.94. Teladoc Health has a 1-year low of $12.65 and a 1-year high of $30.41. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.54 and a quick ratio of 3.47.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.11% and a negative net margin of 8.90%. The business had revenue of $646.13 million for the quarter, compared to analysts’ expectations of $637.31 million. During the same quarter in the prior year, the business earned ($0.37) EPS. The company’s revenue was up 2.7% compared to the same quarter last year. As a group, equities analysts anticipate that Teladoc Health will post -1.07 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other news, insider Arnnon Geshuri sold 7,500 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $15.06, for a total value of $112,950.00. Following the sale, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Jason N. Gorevic sold 53,755 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $14.52, for a total transaction of $780,522.60. Following the completion of the transaction, the chief executive officer now directly owns 653,073 shares of the company’s stock, valued at approximately $9,482,619.96. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Arnnon Geshuri sold 7,500 shares of Teladoc Health stock in a transaction dated Monday, March 25th. The stock was sold at an average price of $15.06, for a total transaction of $112,950.00. Following the transaction, the insider now directly owns 38,470 shares of the company’s stock, valued at $579,358.20. The disclosure for this sale can be found here. Insiders have sold a total of 135,441 shares of company stock worth $2,038,251 in the last three months. Insiders own 1.63% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Large investors have recently made changes to their positions in the company. ICA Group Wealth Management LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth about $28,000. Hexagon Capital Partners LLC boosted its stake in shares of Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after purchasing an additional 1,065 shares during the period. RIA Advisory Group LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth about $36,000. GAMMA Investing LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth about $41,000. Finally, Principal Securities Inc. purchased a new position in shares of Teladoc Health during the 4th quarter worth about $45,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.